0001181431-14-006553.txt : 20140212 0001181431-14-006553.hdr.sgml : 20140212 20140212173425 ACCESSION NUMBER: 0001181431-14-006553 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140211 FILED AS OF DATE: 20140212 DATE AS OF CHANGE: 20140212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Machado Clarence Patrick CENTRAL INDEX KEY: 0001311210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 14601647 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 rrd402211.xml 2/11/14 EXERCISE AND SALE X0306 4 2014-02-11 0 0001011835 MEDIVATION, INC. MDVN 0001311210 Machado Clarence Patrick C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 0 1 0 0 Chief Business Officer and CFO Common Stock 2014-02-11 4 M 0 40000 10.585 A 70830 D Common Stock 2014-02-11 4 S 0 4500 79.73 D 66330 D Common Stock 2014-02-11 4 S 0 22200 80.66 D 44130 D Common Stock 2014-02-11 4 S 0 13300 81.48 D 30830 D Stock Option (Right to Buy) 10.585 2014-02-11 4 M 0 40000 0.00 D 2017-10-01 Common Stock 40000 47294 D Shares sold pursuant to a 10b5-1 Plan. The shares were sold at prices ranging from $79.12 to $80.095. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $80.13 to $81.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $81.1375 to $82.0222. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. /s/ Jennifer J. Rhodes, Attorney-in-fact 2014-02-12